ストックスクリーナーアプリを入手
8.66
5.10%
0.42
プレマーケット:
8.66
前日終値:
$8.24
開ける：
$8.29
24時間の取引高:
800.60K
Relative Volume:
0.86
時価総額：
$447.24M
収益：
$742.90M
当期純損益:
$52.60M
株価収益率:
10.44
EPS:
0.8295
ネットキャッシュフロー:
$156.80M
1週間 パフォーマンス:
+10.32%
1か月 パフォーマンス:
+7.31%
6か月 パフォーマンス:
-4.73%
1年 パフォーマンス:
+89.08%
1日の値動き範囲:
$8.29
$8.84
1週間の範囲:
$7.85
$8.84
52週間の値動き範囲:
$4.44
$14.06
Emergent Biosolutions Inc Stock (EBS) Company Profile
名前
Emergent Biosolutions Inc
セクター
電話
240-631-3200
住所
300 PROFESSIONAL DR, GAITHERSBURG, MD
Compare EBS vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
8.66 | 411.09M | 742.90M | 52.60M | 156.80M | 0.8295 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
| 2024-03-07 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-11-20 | 再開されました | JP Morgan | Underweight |
| 2023-08-29 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-04-10 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-03-17 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-11-10 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-04-29 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | アップグレード | The Benchmark Company | Hold → Buy |
| 2021-11-08 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2021-05-05 | ダウングレード | Argus | Buy → Hold |
| 2021-04-07 | 開始されました | The Benchmark Company | Buy |
| 2021-02-24 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | 再開されました | JP Morgan | Neutral |
| 2020-07-31 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-09-12 | 開始されました | Guggenheim | Buy |
| 2019-09-04 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | アップグレード | Goldman | Neutral → Buy |
| 2018-08-03 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-06-13 | 開始されました | Argus | Buy |
| 2018-04-25 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2018-01-16 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-06-28 | 繰り返されました | Singular Research | Buy |
| 2016-04-15 | 開始されました | Chardan Capital Markets | Buy |
| 2016-03-28 | 開始されました | Singular Research | Buy |
| 2016-02-19 | 開始されました | Wells Fargo | Outperform |
| 2014-05-15 | 開始されました | Summer Street Research | Buy |
| 2011-05-31 | 繰り返されました | WBB Securities | Strong Buy |
| 2011-01-10 | 繰り返されました | Wedbush | Outperform |
| 2010-11-05 | 繰り返されました | Wedbush | Outperform |
| 2010-08-18 | アップグレード | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | 繰り返されました | Caris & Company | Buy |
すべてを表示
Emergent Biosolutions Inc (EBS) 最新ニュース
Emergent BioSolutions (EBS) price target decreased by 11.11% to 12.24 - MSN
Q2 2025 Emergent BioSolutions Inc Earnings Call Transcript - GuruFocus
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness - Bioscience Association Manitoba
Emergent BioSolutions Announces Preliminary 2012 Financial Results and Provides Guidance for 2013 - AOL.com
Emergent BioSolutions Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Emergent Biosolutions partners with British Columbia to supply NARCAN nasal spray for expanded program - Traders Union
Earnings Risk: Is Emergent BioSolutions Inc stock showing strong momentum2026 Earnings Impact & Capital Efficient Trading Techniques - baoquankhu1.vn
Emergent Biosolutions Partners With British Columbia To Supply Narcan® Nasal Spray For The Launch Of The Expanded Bc Take Home Naloxone Program - TradingView — Track All Markets
Emergent BioSolutions (EBS) Partners with B.C. for Nasal Naloxone Expansion - GuruFocus
B.C. puts $18M into nasal naloxone, taps Emergent for NARCAN - Stock Titan
Dimensional Fund Advisors (EBS) reports 2.76M shares, 5.3% stake - Stock Titan
Aug Fed Impact: How does Emergent BioSolutions Inc perform in inflationary periods2026 Big Picture & Advanced Technical Analysis Signals - baoquankhu1.vn
Emergent BioSolutions Inc. (EBS) stock price, news, quote and history - Yahoo Finance UK
Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Emergent BioSolutions (NYSE:EBS) Pulls Back 17% This Week, but Still Delivers Shareholders Strong 101% Return Over 1 Year - 富途牛牛
Emergent BioSolutions Participates in NATO Defense against Terrorism Workshop at the Counter Terror - Yahoo
Emergent Biosolutions Launches New Narcan Nasal Spray Carrying Case and Multipacks - marketscreener.com
Emergent Biosolutions expands opioid overdose preparedness with new NARCAN Nasal Spray solutions - Traders Union
Why Is Emergent BioSolutions Inc. (EBS) Stock Down Today? - Meyka
EBS PE Ratio & Valuation, Is EBS Overvalued - Intellectia AI
Insider Sell: Paul Williams Sells 4,000 Shares of Emergent BioSo - GuruFocus
Emergent BioSolutions (NYSE: EBS) SVP sells 4,000 shares - Stock Titan
Emergent Biosolutions directs 2026 Cycle A donations to public health and scientific outreach - Traders Union
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences - bitget.com
Emergent joins 4 health security events from London to Kuala Lumpur - Stock Titan
[144] Emergent BioSolutions Inc. SEC Filing - Stock Titan
Chart Watch: Is Emergent BioSolutions Inc stock forming a triangle patternEarnings Performance Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Risks Report: Is Emergent BioSolutions Inc stock showing strong momentumShort Setup & Weekly Sector Rotation Insights - baoquankhu1.vn
Emergent BioSolutions Inc. (EBS) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Vanguard disaggregates holdings; reports zero Emergent BioSolutions stake (NYSE: EBS) - Stock Titan
Decliners Report: Can Emergent BioSolutions Inc grow without external fundingQuarterly Profit Report & Accurate Intraday Trading Signals - baoquankhu1.vn
H.C. Wainwright reiterates Emergent BioSolutions stock rating on contract wins - Investing.com Australia
H.C. Wainwright reiterates Emergent BioSolutions stock rating on contract wins By Investing.com - Investing.com South Africa
Emergent BioSolutions secures $60.6M in smallpox contracts By Investing.com - Investing.com Australia
Emergent BioSolutions secures $60M contracts - MSN
Emergent Biosolutions stock rises on $54M government contract By Investing.com - Investing.com Canada
How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story - finance.yahoo.com
Emergent Biosolutions stock rises on $54M government contract - Investing.com
Emergent Biosolutions Inc (EBS) 財務データ
収益
当期純利益
現金流量
EPS
1.06%
1.05%
大文字化:
|
ボリューム (24 時間):